154

Publikationen

Filtern nach:

Filter zurücksetzen

Anzahl gefilterter
Ergebnisse:

T. Ebert, R. Schürfeld, M. Schultze, M. Müller, C.-D. Köhler, J. Birnbaum.  Epidemiology and management of CKD with type 2 diabetes: insights from German claims data.  61st EASD Annual Meeting of the European Association for the Study of Diabetes, 15 - 19 September 2025, Wien. Published in: Diabetologia 68 (Suppl 1), 1–754 (2025).  https://doi.org/10.1007/s00125-025-06497-1

Therapy areas: Cardiovascular, Renal and Metabolism

Indications: Chronic Kidney Disease

Jens Aberle, Daniel Duerschmied, Martin Grond, Michael Lehrke, Stephan Martin, Sven-Oliver Tröbs, Michael Schultze, Nils Kossack, Lena Margareta Richter, Maximilian Gabler.  Treatment and associated outcomes of type 2 diabetes mellitus patients with a cardiovascular comorbidity and comparison with guideline recommendations: a German claims data analysis.  Cardiovasc Diabetol 24, 364 (2025).  https://doi.org/10.1186/s12933-025-02864-9

Therapy areas: Cardiovascular, Renal and Metabolism

Indications: Diabetes Type 2

Thomas Kuhnt, Nils Kossack, Lena Richter, Michael Schultze, Ulrike Osowski, Luisa Henkel, Ann-Christin Gaupel, Nancy Schoenherr. Real-world treatment patterns and survival outcomes associated with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN): A German claims data analysis. European Society for Medical Oncology (ESMO) Congress 2024, 13. – 17. Sept. 2024, Barcelona. No DOI/URL available

Therapy areas: Oncology/Hematology

Indications: Head and Neck Cancer

Claus F Vogelmeier , Felix W Friedrich , Patrick Timpel , Nils Kossack , Joanna Diesing , Marc Pignot , Melanie Abram , Michael Gediga , Marija Halbach. Comorbidities and cause of death in COPD patients compared to non-COPD controls: an 8-year observational retrospective healthcare claims database cohort study.  Pneumologie 79(S 01):S16-S16. https://doi.org/10.1055/s-0045-1804570

Therapy areas: Respiratory

Indications: COPD

Shona Fang, Peter Hedera, Julia Borchert, Michael Schultze, Karl Heinz Weiss. Epidemiology of Wilson disease in Germany – real-world insights from a claims data study. Orphanet J Rare Dis 19, 335 (2024). https://doi.org/10.1186/s13023-024-03351-2

Therapy areas: Rare Disease

Indications: Rare Disease - Wilson Disease

M. C. Banas, B. Banas, M. Schultze, M. Müller, C. Gollop, J. Birnbaum. Atlas-CKD – Aktuelle Epidemiologie und Gesundheitskennzahlen von CKD Patient:innen in Deutschland. Jahrestagung der Deutschen Gesellschaft für Nephrologie (DGfN), 26.–29. September 2024, Berlin. Chronic Kidney Disease

Indications: Cardiovascular, Renal and Metabolism

M.C. Banas, M. Müller, M. Schultze, D. Stengel, J. Birnbaum, B. Banas. J.T. Kielstein.  Analyse zur wirtschaftlichen Belastung des deutschen Gesundheitssystems durch CKD-Patient:innen: Erkenntnisse aus der ATLAS-CKD Sekundärdatenanalyse.  17. Jahrestagung der Deutschen Gesellschaft für Nephrologie e.V. (DGfN) 02. – 05. Oktober 2025, Berlin, veröffentlich in: ISSN 1869–9405 ZKZ 18874. No DOI/URL available

Therapy areas: Cardiovascular, Renal and Metabolism

Indications: Chronic Kidney Disease

M. Haubitz, M. Schultze, M. Müller, C.-D. Köhler, J. Birnbaum, B. Banas, M.C. Banas.  Geschlechtsspezifische Unterschiede bei CKD in Deutschland: Eine retrospektive Analyse von Krankenkassendaten.  17. Jahrestagung der Deutschen Gesellschaft für Nephrologie e.V. (DGfN) 02. – 05. Oktober 2025, Berlin veröffentlich in: ISSN 1869–9405 ZKZ 18874. No DOI/URL available

Therapy areas: Cardiovascular, Renal and Metabolism

Indications: Chronic Kidney Disease

Akin Atmacaa, Christian Grohéb, Moritz Klinghardt, Nils Kossack, Marc Pignot, Roxana Schuhe.  A real-world evaluation of brain imaging in patients with advanced NSCLC — insights from a German claims data analysis.  Oncol Res Treat (2025).  https://doi.org/10.1159/000547215

Therapy areas: Oncology/Hematology

Indications: NSCLC

Claus F Vogelmeier , Felix W Friedrich , Patrick Timpel , Nils Kossack , Joanna Diesing , Marc Pignot , Melanie Abram , Michael Gediga , Marija Halbach.  Comorbidities and Cause of Death in COPD Patients Compared to Non-COPD Controls: An 8-year Observational Retrospective Healthcare Claims Database Cohort Study.  Int J Chron Obstruct Pulmon Dis. 2025 Jun 27:20:2117-2130.  https://doi.org/10.2147/COPD.S488701

Therapy areas: Respiratory

Indications: COPD

Schnabel RB, Witt H, Walker J, Ludwig M, Geelhoed B, Kossack N, Schild M, Miller R, Kirchhof P. Machine learning-based identification of risk-factor signatures for undiagnosed atrial fibrillation in primary prevention and post- stroke in clinical practice Eur Heart J Qual Care Clin Outcomes. 2022 Dec 13;9(1):16-23 doi: 10.1093/ehjqcco/qcac013.

Therapy areas: Cardiovascular, Renal and Metabolism

Indications: Cardiac Arrhythmia

V. Fuhrmann, F. Tacke, M. Schultze, N. Kossack, K. Kopke, F. Scherg, J. Trebicka. Epidemiologie und klinischer Verlauf von gastrointestinalen Blutungen unter Behandlung mit oralen Faktor-Xa-Inhibitoren in Deutschland. DGVS Viszeralmedizin 2024, 30. September – 05. October 2024, Leipzig. GI Bleeding

Indications: Gastroenterology

Wende, D., Karmann, A. & Weinhold, I. Deprivation as a fundamental cause of morbidity and reduced life expectancy: an observational study using German statutory health insurance data Int J Health Econ Manag. 24, 257–277 (2024). https://doi.org/10.1007/s10754-024-09374-3

Therapy areas: General Health

Indications: General

Neumann A, Kliemt R, Baum F, Seifert M , Kubat D , March S , Weinhold I, Swart E, Schmitt J An Experience Report on the Evaluation of New Forms of Care for People with Mental Illness: Pros and Cons of the Use of SHI Claims Data Gesundheitswesen 2024; 86(S 03): S212-S223 DOI: 10.1055/a-2297-5347

Therapy areas: Psychiatry

Indications: Mental disorders

Vanessa Brunetti, Min Kim, Nils Kossack, Michael Schultze, James O’Kelly. Comparability of new users of denosumab, oral bisphosphonates and intravenous bisphosphonates in Germany: A retrospective real-world cohort study. American Society for Bone and Mineral Research (ASBMR) Annual Meeting 2024, 27.–30. September 2024, Toronto. Osteoporosis

Indications: Bone

Svensson MK, Fischereder M, Kalra PR, Sánchez Lázaro IJ, Lesén E, Franzén S, Allum A, Cars T, Kossack N, Breitbart P, Arroyo D. Hyperkalemia-Related RAASi Reduction and Estimated Number Needed to Treat to Avoid a First Hospitalization by Maintaining RAASi Kidney360. 2024 Aug 21. Epub ahead of print. doi: 10.34067/KID.0000000000000561.

Therapy areas: Cardiovascular, Renal and Metabolism

Indications: Hyperkalemia

Vogelmeier CF, Beeh KM, Schultze M, Kossack N, Richter LM, Claussen J, Compton C, Noorduyn SG, Ismaila AS, Requena G. Evaluation of Adherence and Persistence to Triple Therapy in Patients with COPD: A German Claims Data Study. Int J Chron Obstruct Pulmon Dis. 2024 Aug 9;19:1835-1848. doi: 10.2147/COPD.S460903.

Therapy areas: Respiratory

Indications: COPD

Ehehalt, R. & Kaiser, S. & Kudernatsch, R. & Schmidt, S. & Kossack, N. Einblick in Epidemiologie und Behandlungspfade deutscher Patienten mit chronischer Pouchitis, die eine über Antibiotika hinausgehende Therapie benötigen, durch Verwendung von Krankenkassendaten Zeitschrift für Gastroenterologie. 61 10.1055/s-0043-1771745.

Therapy areas: Gastroenterology

Indications: Inflammatory bowel disease

Brestrich G, Diesing J, Kossack N, Stark JH, Pilz A, Yu H, Suess J. Excess Healthcare Costs and Resource Utilisation of Lyme Borreliosis in Germany: A Propensity Score-Matched Cohort Study. Zoonoses Public Health. 2024 Sep 5. Epub ahead of print. doi: 10.1111/zph.13180.

Therapy areas: Infectious Diseases

Indications: Lyme Borreliosis

Wick M, Kliemt R, Poshtiban A, Kossack N, Diller GP, Soudani S, Bangert M, Kramer R, Damm O. Respiratory syncytial virus immunization patterns in Germany, 2015-2020. Hum Vaccin Immunother. 2024 Dec 31;20(1):2380110. doi: 10.1080/21645515.2024.2380110.

Therapy areas: Infectious Diseases

Indications: RSV

12345678